A Decade of Marketing Authorization Applications of Anticancer Drugs in the European Union: An Analysis of Procedural Timelines

por Garsen, Marjolein, Steenhof, Maaike, Zwiers, Alex
Publicado 2021

Healthy Volunteer Studies in the Development of Anticancer Drugs with Genotoxic Findings

por Omes-Smit, Grace, Garsen, Marjolein, Zwiers, Alex
Publicado 2021

Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy

por Buijsers, Baranca, Garsen, Marjolein, de Graaf, Mark, Bakker-van Bebber, Marinka, Guo, Chunming, Li, Xue, van der Vlag, Johan
Publicado 2023

Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria

por Garsen, Marjolein, Rops, Angelique L., Li, Jinhua, van Beneden, Katrien, van den Branden, Christiane, Berden, Jo HM, Rabelink, Ton J., van der Vlag, Johan
Publicado 2016

Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice

por Gil, Natali, Goldberg, Rachel, Neuman, Tzahi, Garsen, Marjolein, Zcharia, Eyal, Rubinstein, Ariel M., van Kuppevelt, Toin, Meirovitz, Amichay, Pisano, Claudio, Li, Jin-Ping, van der Vlag, Johan, Vlodavsky, Israel, Elkin, Michael
Publicado 2012

Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria

por Garsen, Marjolein, Buijsers, Baranca, Sol, Marloes, Gockeln, Lena, Sonneveld, Ramon, van Kuppevelt, Toin H., de Graaf, Mark, van den Born, Jacob, Kamps, Jan A.A.M., van Raalte, Daniël H., van der Meer, Rutger W., Lamb, Hildo J., Hillebrands, Jan-Luuk, Rabelink, Ton J., Maciej-Hulme, Marissa L., Krenning, Guido, Nijenhuis, Tom, van der Vlag, Johan
Publicado 2023